Company intelligence / Profile preview

Bioam

Paris, France

Ownership: Private
Development stage: Other

Overview

Bioam Gestion was a prominent French venture capital firm founded in 2000 that specialized in early-stage investments within the life sciences, biotechnology, and healthcare sectors. Based in Paris, the firm played a critical role in the development of the French biotech ecosystem, managing specialized funds such as Bioam and advising on the InnoBio fund. In 2010, Bioam merged with CDC Entreprises (now part of Bpifrance), the French public investment bank, to consolidate life science investment activities. During its active period, it supported numerous successful biotechs, including Innate Pharma, Adocia, and Poxel.

Industry: Investors

Partnerships

SanofiGSKRocheNovartisPfizer

Beyond the preview

Go deeper on Bioam.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioam.

Explore the full profile